EIM
RCKT icon

Essex Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Essex Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-52,074
Closed -$772K – 506
2018
Q4 		$772K Buy
52,074
+24,050
+86% +$399K 0.12% 223
2018
Q3 		$690K Buy
28,024
+12,420
+80% +$269K 0.08% 269
2018
Q2 		$306K Buy
+15,604
New +$295K 0.04% 336

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Essex Investment Management's RCKT Position: Q1 2019 in Review

Essex Investment Management sold out of Rocket Pharmaceuticals (RCKT) in Q1 2019, closing a stake of 52,074 shares — an estimated $772K sold.

Essex Investment Management first reported a position in RCKT in Q2 2018 and held it in 3 quarters. The position peaked at $772K in Q4 2018. 81 funds tracked by Wall St. Rank hold RCKT as of Q1 2019.

  • Essex Investment Management reported no remaining Rocket Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Essex Investment Management sold 52,074 Rocket Pharmaceuticals shares in Q1 2019, an estimated $772K.
  • Essex Investment Management first reported a position in Rocket Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Essex Investment Management's Rocket Pharmaceuticals position peaked at $772K in Q4 2018.
  • 81 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2019.

Based on Essex Investment Management's 13F filing for Q1 2019, filed 15 May 2019.